Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first ...

Dear reader, when we discuss the best-selling medications of all time, we’re exploring more than just products with massive ...

Traumatic spinal cord injury has been linked to an elevated long-term risk for neurologic, psychiatric, cardiovascular, and ...

Colon cancer (also called colorectal cancer) is no longer just a disease of older adults — its incidence is rising sharply ...

Two Massachusetts men accused of setting off an explosion at Harvard Medical School are now facing federal charges.

Artrya Limited has announced that Mass General Brigham, a leading U.S. center for cardiac care, will participate in the SAPPHIRE Study, a retrospective multi-center trial set to begin in early 2026.

CSL has used the first session of its capital markets fiesta in Chicago to assure investors the company has a flu vaccine ...

Khateeb, Minister of Tourism, the city of Riyadh witnessed the launch of a Saudi-Swiss partnership during the “TOURISE 2025” Summit, aimed at advancing innovation, developing national talent, and ...

AISAP, a leader in AI Point-of-Care Diagnostics, today announced a landmark field initiative in Ghana, deploying the company's FDA-cleared AI-powered cardiac diagnosis platform. The program will ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved prostat ...

Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...